| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/04/2006 | CA2583026A1 Hcv vaccines for chronic hcv patients |
| 05/04/2006 | CA2580919A1 Gastric inhibitory polypeptide (gip) antigen arrays and uses thereof |
| 05/03/2006 | EP1652931A2 Recombinant adenoviruses, preparation and uses thereof for the treatment and/or prevention ofs cancers |
| 05/03/2006 | EP1652925A1 IgM PRODUCTION BY TRANSFORMED CELLS AND METHODS FOR QUANTIFYING SAID IgM PRODUCTION |
| 05/03/2006 | EP1652923A1 Gene overexpressed in cancer |
| 05/03/2006 | EP1652914A1 Virosome particles comprising antigens from influenza virus and Hepatitis B virus |
| 05/03/2006 | EP1652859A1 Immunoglobulin fractions |
| 05/03/2006 | EP1652858A1 Peptides for inducing a CTL and/or HTL response to hepatitis C virus |
| 05/03/2006 | EP1652857A2 Fusion protein of HIV regulatory/accessory proteins |
| 05/03/2006 | EP1652856A1 Stress proteins-derived peptides and method of use thereof |
| 05/03/2006 | EP1651765A2 Protein from photobacterium damselae and use thereof |
| 05/03/2006 | EP1651684A1 Etherified carbamate functional copolymers of isobutylene type monomers, and their use in curable compositions |
| 05/03/2006 | EP1651676A2 Therapy-enhancing glucan |
| 05/03/2006 | EP1651667A1 Protein with fusogenic activity, nucleic acid sequences encoding said protein and pharmaceutical compositions comprising the same |
| 05/03/2006 | EP1651666A1 Alphavirus-based cytomegalovirus vaccines |
| 05/03/2006 | EP1651663A2 Bispecific antibodies for inducing apoptosis of tumor and diseased cells |
| 05/03/2006 | EP1651271A2 Compositions and methods for treating coronavirus infection and sars |
| 05/03/2006 | EP1651269A2 Monoclonal antibodies against ricin toxin and methods of making and using thereof |
| 05/03/2006 | EP1651267A1 Methods of therapy for chronic lymphocytic leukemia |
| 05/03/2006 | EP1651266A1 Administration of anti-cytokine f(ab')2 antibody fragments |
| 05/03/2006 | EP1651265A2 Vaccine formulations comprising an oil-in-water emulsion |
| 05/03/2006 | EP1651264A1 Subunit vaccine against respiratory syncytial virus infection |
| 05/03/2006 | EP1651263A2 Safe mutant viral vaccines |
| 05/03/2006 | EP1651262A2 Process for preparing polysaccharide-protein conjugate vaccines |
| 05/03/2006 | EP1651261A2 Polysaccharide-protein conjugate vaccines |
| 05/03/2006 | EP1651259A2 Methods and compositions for producing antigenic responses |
| 05/03/2006 | EP1651258A2 Hepatitis virus core proteins as vaccine platforms and methods of use thereof |
| 05/03/2006 | EP1651257A1 Targeted therapeutic vaccine against p-glycoprotein 170 for inhibiting multi-drug resistance in the treatment of cancers |
| 05/03/2006 | EP1651256A1 Human prostate cell lines in cancer treatment |
| 05/03/2006 | EP1651247A1 Treatment and diagnosis of neoplasms using thymic stromal lymphopoietin |
| 05/03/2006 | EP1651169A2 Combination therapies for multiple sclerosis |
| 05/03/2006 | EP1651166A2 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 05/03/2006 | EP1651038A2 Tissue adhesive sealant |
| 05/03/2006 | EP1317273B1 Use of il-6r/il-6 chimera in huntington's disease |
| 05/03/2006 | EP1242060B1 Treatment of metastatic disease |
| 05/03/2006 | EP1212088B1 Use of anti rubeola antibodies for treatment of symptoms of central nervous system disorders |
| 05/03/2006 | EP1105484B1 Antithrombin nucleotides and proteins from horn fly |
| 05/03/2006 | EP1015481B1 Antigenic structural peptide, antigenic and immunogenic compounds and uses for detecting, preventing and treating an hcv infection |
| 05/03/2006 | EP0793500B1 Pharmaceutical compositions comprising nitric oxide-releasing polysaccharides |
| 05/03/2006 | EP0625047B1 Platelet transfusion |
| 05/03/2006 | CN1768140A A high-troughput diagnostic assay for the human virus causing severe acute respiratory syndrome (SARS) |
| 05/03/2006 | CN1768079A Polypeptide |
| 05/03/2006 | CN1768078A Antibodies directed against hepatitis c virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions |
| 05/03/2006 | CN1767860A Methods and compositions for administering therapeutic and diagnostic agents |
| 05/03/2006 | CN1767854A Microfluidized oil-in-water emulsions and vaccine compositions |
| 05/03/2006 | CN1767853A Mucosal meningococcal vaccines |
| 05/03/2006 | CN1767852A Antibody vaccine conjugates and uses therefor |
| 05/03/2006 | CN1765931A GLP-1 fusion protein and its preparation method and medicinal uses |
| 05/03/2006 | CN1765928A Reconstituted human anti-hm1.24 antibody |
| 05/03/2006 | CN1765418A REV(reticuloendotheliosis virus) subunit vaccine and its production method |
| 05/03/2006 | CN1765370A Method for preparing anti-aftosa serum |
| 05/03/2006 | CN1254541C Novel compound |
| 05/03/2006 | CN1254487C Reformed monoclonal antibody for resisting immunoglobulin homoeotype |
| 05/03/2006 | CN1254485C Human lung cancer antigen and its antibody |
| 05/03/2006 | CN1254275C Antithrombotic agent and anti-von willebrand factor monoclonal antibodies |
| 05/03/2006 | CN1254272C Activation and inhibition of immune system |
| 05/03/2006 | CN1254187C Ice-cream for preventing decayed tooth |
| 05/02/2006 | US7038077 2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives; nervous system, psychological, and psychiatric disorders |
| 05/02/2006 | US7038035 Nucleic acids codes polypeptides; mutants; insertion a vector; culturing; recovering |
| 05/02/2006 | US7038029 Vaccination |
| 05/02/2006 | US7038020 Diagnosis of RH factor; using polypeptides to form antibodies |
| 05/02/2006 | US7038018 Antibodies and ligands for “Bonzo” chemokine receptor |
| 05/02/2006 | US7038017 Antibody purification |
| 05/02/2006 | US7038016 Dissolving a stable, activated polyoxyethylene glycol (carboxymethyloxy-end group)(aPEG) in a solvent; filtering the the solution to reduce the bioburden/endotoxin levels; used for the preparation of a PEGylated hemoglobin solution |
| 05/02/2006 | US7038013 Nucleotide sequences coding polypeptide for use in treatment of immune respone defects |
| 05/02/2006 | US7038012 Enrichment process for H. pylori neutrophil activating protein (NAP) utilizing metal chelate chromatography |
| 05/02/2006 | US7037896 HIV inhibiting peptide (VIRIP) and amidated, acetylated, sulfated, polyethylene glycol modified, phosphorylated and/or glycosylated derivatives |
| 05/02/2006 | US7037702 Hydrolase polypeptide for dephosphorylating mitogen activated kinases (MAP-kinase); antiapoptosis; antiproliferative agents |
| 05/02/2006 | US7037681 Plasmodium falciparum merozoite surface protein-1 malaria produced in transgenic plants |
| 05/02/2006 | US7037680 Generation of botulinum neurotoxin light chain; culture cells coding botulinum neurotoxin light chain, express genes, recover protein |
| 05/02/2006 | US7037668 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616 |
| 05/02/2006 | US7037652 Diagnosing prostate cancer in humans; obtain tissue sample, monitor gene expression, compare to control, evaluate for cancer |
| 05/02/2006 | US7037647 Prostate-specific membrane antigen and uses thereof |
| 05/02/2006 | US7037510 Hybrids of M. tuberculosis antigens |
| 05/02/2006 | US7037509 Immunologically significant herpes simplex virus antigens and methods for using same |
| 05/02/2006 | US7037508 Pestivirus mutants and vaccines containing the same |
| 05/02/2006 | US7037507 T helper cell epitopes |
| 05/02/2006 | US7037506 Vaccine accelerator factor (VAF) for improvement of vaccinations in poultry |
| 05/02/2006 | US7037503 Compounds and methods for the treatment and prevention of bacterial infection |
| 05/02/2006 | US7037502 Peptide for use in the treatment of inflammation |
| 05/02/2006 | US7037501 Administering to the egg- laying vertebrate or to an egg of the vertebrate the vaccine of immunoconjugate of myostatin polypeptide linked to a carrier to increase muscle weight |
| 05/02/2006 | US7037500 Method for using phagocytic particles and ATP receptors to deliver antigens to MHC class I receptors to induce immunity against microbial pathogens or tumors or to suppress immunity |
| 05/02/2006 | US7037499 Adjuvant for transcutaneous immunization |
| 05/02/2006 | US7037498 Antibodies to insulin-like growth factor I receptor |
| 05/02/2006 | US7037496 Chimeric immunoglobulin for CD4 receptors |
| 05/02/2006 | US7037495 Antimicrobial compositions |
| 05/02/2006 | US7037450 Production scale method of forming microparticles |
| 05/02/2006 | US7037332 Medical device with coating that promotes endothelial cell adherence |
| 05/02/2006 | CA2149529C Peptides and anti-sense peptides with broad neoplastic specificity |
| 04/27/2006 | WO2006045110A2 High cell density process for growth of listeria |
| 04/27/2006 | WO2006045049A1 Angiopoietin-2 specific binding agents |
| 04/27/2006 | WO2006044864A2 Vaccine adjuvant |
| 04/27/2006 | WO2006044857A2 Vaccines against japanese encephalitis virus and west nile virus |
| 04/27/2006 | WO2006044643A2 Anti-cd70 antibody and its use for the treatment and prevention of cancer and immune disorders |
| 04/27/2006 | WO2006044433A2 Methods to treat or prevent viral-associated lymphoproliferative disorders |
| 04/27/2006 | WO2006044410A2 A32 monoclonal antibody fusion proteins for use as hiv inhibitors and vaccines |
| 04/27/2006 | WO2006044333A2 Methods and materials for the inhibition of transplant rejection |
| 04/27/2006 | WO2006044330A2 Anticancer compounds and methods |
| 04/27/2006 | WO2006044263A2 Treatment of herpes |
| 04/27/2006 | WO2006043891A1 Immunoregulation in cancer, chronic inflammatory and autoimmune diseases |